Literature DB >> 6786950

Gastric pepsin and acid secretion in patients with acute and healed duodenal ulcer.

J L Achord.   

Abstract

The relationship between gastric pepsin, acid secretion, and duodenal ulcer activity was studied in 33 patients with an endoscopically proven carter, in 17 patients who were studied within 3 mo of an acute crater but who no longer had a crater endoscopically, and in 10 patients who had no duodenal ulcer symptoms for longer than 3 mo after a crater and who had negative endoscopy. There were an additional 11 patients who had paired studies in the early-healed and late-healed stages of their disease. There were no significant differences between the values obtained in the paired and nonpaired group. Basal and pentagastrin-stimulated outputs of both pepsin and acid were significantly higher (p less than 0.001) when an acute crater was present than in 23 control subjects. At 3 mo or more after healing there was a significant (p less than 0.001) fall in both basal and stimulated pepsin and acid output which became insignificantly different from that of controls. In 104 basal studies the ratio of pepsin to acid secretion was 33,000 +/- 2500 (mean +/- SE) pepsin units/mmol H+ with no difference between any groups including controls. In 102 stimulated studies the ratio was 13,600 +/- 400 PU/mmol H+, also with no differences between any groups. Although data in the literature are conflicting, these results support a direct relationship between the activity of duodenal ulcer disease and acid-pepsin secretion.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6786950

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  11 in total

Review 1.  Pepsinogen.

Authors:  B I Hirschowitz
Journal:  Postgrad Med J       Date:  1984-11       Impact factor: 2.401

2.  Changes in nocturnal and peak acid outputs after duodenal ulcer healing with sucralfate or ranitidine.

Authors:  A F Kummer; D A Johnston; I N Marks; G O Young; N A Tigler-Wybrandi; S A Bridger
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

3.  Behaviour of acid secretion, gastrin release, serum pepsinogen I, and gastric emptying of liquids over six months from eradication of helicobacter pylori in duodenal ulcer patients. A controlled study.

Authors:  F Parente; G Maconi; O Sangaletti; M Minguzzi; L Vago; G Bianchi Porro
Journal:  Gut       Date:  1995-08       Impact factor: 23.059

4.  Does smoking interfere with the effect of histamine H2-receptor antagonists on intragastric acidity in man?

Authors:  P Bauerfeind; T Cilluffo; C J Fimmel; C Emde; C von Ritter; W Kohler; R Gugler; T Gasser; A L Blum
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

5.  Circadian pattern of intragastric acidity in duodenal ulcer patients: a study of variations in relation to ulcer activity.

Authors:  S Wagner; U Gladziwa; M Gebel; A Schüler; J Freise; F W Schmidt
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

6.  Increased parietal cell responsiveness to tetragastrin in patients with recurrent duodenal ulcer.

Authors:  A Yanaka; H Muto
Journal:  Dig Dis Sci       Date:  1988-11       Impact factor: 3.199

7.  Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobacter pylori.

Authors:  S F Moss; J Calam
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

8.  Measurement of plasma group I pepsinogens.

Authors:  D F Levine; M Beer
Journal:  Postgrad Med J       Date:  1984-09       Impact factor: 2.401

9.  Effect of H2-receptor blockade by ranitidine on ulcer healing and gastric acid secretion in patients with gastric and duodenal ulcers.

Authors:  H Forssell; G Koch
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

10.  Tolerance and rebound to H2-receptor antagonists: intragastric acidity in patients with duodenal ulcer.

Authors:  C H Wilder-Smith; F Halter; H S Merki
Journal:  Dig Dis Sci       Date:  1991-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.